Company Filing History:
Years Active: 2016
Title: The Innovations of Göran Tornling
Introduction
Göran Tornling is a notable inventor based in Enebyberg, Sweden. He has made significant contributions to the field of medicine, particularly in the treatment of airway hyperresponsiveness. His innovative approach has led to the development of a unique method that utilizes pemirolast for therapeutic purposes.
Latest Patents
Göran Tornling holds a patent for the use of pemirolast. This invention provides a method for treating airway hyperresponsiveness, which involves administering pemirolast, or a pharmaceutically acceptable salt thereof, to patients in need of such treatment. The recommended lower doses of pemirolast are at least about 110 mg per day. This patent highlights his commitment to improving patient care through innovative solutions.
Career Highlights
Throughout his career, Göran has been associated with Rspr Pharma AB, where he has played a crucial role in advancing pharmaceutical research and development. His work has focused on creating effective treatments that address significant health challenges.
Collaborations
Göran Tornling has collaborated with several professionals in his field, including Johan Raud and Carl-Johan Dalsgaard. These partnerships have contributed to the success of his projects and the advancement of medical treatments.
Conclusion
Göran Tornling's contributions to the field of medicine through his patent on pemirolast demonstrate his innovative spirit and dedication to improving healthcare. His work continues to impact the lives of patients in need of effective treatments.